Contact
searchSearch
HMP Global

Hair and Trichology Topic Center

Featured

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
alopecia areata
News
Mast Cells and Plasma Possible Markers for Alopecia Areata and Periodontitis
09/22/2023
Jessica Garlewicz
Researchers aimed to delve into the connection between alopecia areata and periodontitis.
Researchers aimed to delve into the connection between alopecia areata and periodontitis.
Researchers aimed to delve into...
09/22/2023
The Dermatologist

Expert Insights

Dr Natasha Atanaskova Mesinkovska
Podcasts
Dr Natasha Atanaskova Mesinkovska on Alopecia Areata
05/16/2023
Natasha Atanaskova Mesinkovska, MD, PhD
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr...
05/16/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Growing in Your Hair Practice
02/16/2021
Lauren Mateja
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With...
02/16/2021
The Dermatologist
Treating Androgenetic Alopecia: A Review of Nonsurgical Options
Feature Story
Treating Androgenetic Alopecia: A Review of Nonsurgical Options
07/15/2020
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
...
07/15/2020
The Dermatologist
Feature Story
Hair Loss Treatments: A Word of Caution
09/04/2008
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population...
09/04/2008
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
HSF-Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Cover Story
Type 2 Inflammation in Atopic Dermatitis
08/02/2025
Mona Shahriari, MD, FAAD
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a...
08/02/2025
The Dermatologist
Feature Story
GLP-1 Agonists: Implications for Dermatology
08/02/2025
Serene Majid, BA; Steven R. Feldman, MD, PhD
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an...
08/02/2025
The Dermatologist

News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriasis
News
Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities
07/10/2025
Jessica Garlewicz
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of...
07/10/2025
The Dermatologist

Quizzes and Polls

Quiz
Trivia: Alopecia Areata
03/29/2019
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among...
03/29/2019
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist
JAK Inhibitors - headache
Quiz
Alopecia Areata—JAK Inhibitors
08/14/2025
Jessica Garlewicz
What is the most likely reason JAK inhibitors are effective in AA?
What is the most likely reason JAK inhibitors are effective in AA?
What is the most likely reason...
08/14/2025
The Dermatologist
Quiz
Medical Minimization of AA: What Contributed Historically?
08/14/2025
Riya Gandhi, MA
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Test your knowledge of how...
08/14/2025
The Dermatologist
Quiz
Why Is Alopecia So Emotionally Impactful? Evolution Holds Clues
07/29/2025
Riya Gandhi, MA
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
Discover the evolutionary theory...
07/29/2025
The Dermatologist
Atopic dermatitis
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Recent News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriasis
News
Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities
07/10/2025
Jessica Garlewicz
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of psoriasis pathophysiology continues to evolve, treatment goals may need to expand accordingly.
As the understanding of...
07/10/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use